Search filters

List of works by Markus Möbs

Allogeneic partially HLA-matched dendritic cells pulsed with autologous tumor cell lysate as a vaccine in metastatic renal cell cancer: a clinical phase I/II study

scientific article published on 04 March 2013

Analysis of the IL-31 pathway in Mycosis fungoides and Sézary syndrome

scientific article

Apoptosis induction by SAHA in cutaneous T-cell lymphoma cells is related to downregulation of c-FLIP and enhanced TRAIL signaling.

scientific article published on 3 May 2012

Aurora Kinase A Is Upregulated in Cutaneous T-Cell Lymphoma and Represents a Potential Therapeutic Target.

scientific article

Cutaneous malignant lymphomas. Update on diagnosis and therapy of cutaneous T-cell lymphomas

scientific article published in May 2012

DNA copy number changes define spatial patterns of heterogeneity in colorectal cancer.

scientific article

Dimethyl fumarate restores apoptosis sensitivity and inhibits tumor growth and metastasis in CTCL by targeting NF-κB.

scientific article published on 06 June 2016

Establishment of the First Well-differentiated Human Pancreatic Neuroendocrine Tumor Model

scientific article published on 12 January 2018

Evaluation of T-cell clonality in archival skin biopsy samples of cutaneous T-cell lymphomas using the biomed-2 PCR protocol.

scientific article published on June 2010

Evaluation of blood parameters for the monitoring of erythrodermic cutaneous T-cell lymphoma

scientific article published on 01 January 2015

Genome-Wide Analysis of Interchromosomal Interaction Probabilities Reveals Chained Translocations and Overrepresentation of Translocation Breakpoints in Genes in a Cutaneous T-Cell Lymphoma Cell Line.

scientific article published on 30 May 2018

Genomic loss of the putative tumor suppressor gene E2A in human lymphoma.

scientific article

IL-32 induces indoleamine 2,3-dioxygenase+CD1c+ dendritic cells and indoleamine 2,3-dioxygenase+CD163+ macrophages: Relevance to mycosis fungoides progression

scientific article published on 5 May 2016

IL32 is progressively expressed in mycosis fungoides independent of helper T-cell 2 and helper T-cell 9 polarization.

scientific article

Identification of multiple complex rearrangements associated with deletions in the 6q23-27 region in Sézary syndrome.

scientific article published on 18 April 2013

Inactivation of RUNX3/p46 Promotes Cutaneous T-Cell Lymphoma.

scientific article published on July 2016

Mechanisms of targeting the MDM2-p53-FOXM1 axis in well-differentiated intestinal neuroendocrine tumors

scientific article published on 14 September 2017

Molecular diagnostics in cutaneous lymphomas.

scientific article published in May 2013

Mutational Diversity and Therapy Response in Breast Cancer: A Sequencing Analysis in the Neoadjuvant GeparSepto Trial

scientific article published on 12 April 2019

Next-generation sequencing of immunoglobulin gene rearrangements for clonality assessment: a technical feasibility study by EuroClonality-NGS

scientific article published on 13 June 2019

Nonsteroidal anti-inflammatory drugs induce apoptosis in cutaneous T-cell lymphoma cells and enhance their sensitivity for TNF-related apoptosis-inducing ligand

scientific article

Pathogenesis of Mycosis fungoides ⬇️

scientific article published on 03 March 2011

Proteasome inhibitor bortezomib enhances the effect of standard chemotherapy in small cell lung cancer.

scientific article published on 23 September 2017

T helper cell-mediated interferon-gamma expression after human parvovirus B19 infection: persisting VP2-specific and transient VP1u-specific activity

scientific article published in October 2005

T-cell receptor gene rearrangement analysis of sequential biopsies in cutaneous T-cell lymphomas with the Biomed-2 PCR reveals transient T-cell clones in addition to the tumor clone

scientific article published in July 2014

The Effects of Arsenic Trioxide in Combination with Retinoic Acids on Cutaneous T-Cell Lymphoma Cell Lines.

scientific article published on 23 March 2016

The selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models.

scientific article

The tumour suppressor p53 is frequently nonfunctional in Sézary syndrome.

scientific article

Tumor suppressor TNFAIP3 (A20) is frequently deleted in Sézary syndrome.

scientific article published on 31 May 2011

Zanolimumab, a human monoclonal antibody targeting CD4 in the treatment of mycosis fungoides and Sézary syndrome

scientific article published in December 2008

Paulina is supported by:

About Paulina

Help